• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE 0.00% 46.0¢

RECCE PHARMACEUTICALS LTD - Announcements

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

RCE receives grant from US Department of Defence

Announcements


RCE WA Government Sponsorship for BIO Korea 202308/05/23 download Created with Sketch. 310.63KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/04/23 download Created with Sketch. 710.13KB
RCE Ethics Approval to Start Phase I/II (I.V.) Clinical TrialPRICE SENSITIVE17/04/23 download Created with Sketch. 258.68KB
RCE RECCE Trademark Registered - Israel12/04/23 download Created with Sketch. 263.79KB
RCE New Family 4 Patent to be Granted for RECCE Anti-InfectivesPRICE SENSITIVE11/04/23 download Created with Sketch. 272.7KB
RCE Recce Receives Further A$973,144 R&D AdvancePRICE SENSITIVE04/04/23 download Created with Sketch. 220.97KB
RCE Corporate Presentation - WI Emergence 2023PRICE SENSITIVE23/03/23 download Created with Sketch. 2.82MB
RCE Appendix 4D and Interim Financial ReportPRICE SENSITIVE27/02/23 download Created with Sketch. 312KB
RCE Investor Presentation - Spark Plus Biotech Day24/02/23 download Created with Sketch. 4.01MB
RCE Recce Selects CMAX for Phase I/II UTI Clinical TrialPRICE SENSITIVE20/02/23 download Created with Sketch. 393.65KB
RCE Cleansing Statement14/02/23 download Created with Sketch. 158.39KB
RCE Application for quotation of securities - RCE14/02/23 download Created with Sketch. 24.79KB
RCE RECCE Trademark Registered - Hong Kong02/02/23 download Created with Sketch. 234.19KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/01/23 download Created with Sketch. 613.04KB
RCE A$6.21m Received from R&D Rebate PaymentsPRICE SENSITIVE25/01/23 download Created with Sketch. 317.75KB
RCE Cleansing Statement11/01/23 download Created with Sketch. 159.46KB
RCE Application for quotation of securities - RCE11/01/23 download Created with Sketch. 24.79KB
RCE JP Morgan Healthcare ConferencePRICE SENSITIVE10/01/23 download Created with Sketch. 3.42MB
RCE Australian Patent to be Granted for RECCE Anti-InfectivesPRICE SENSITIVE10/01/23 download Created with Sketch. 250.74KB
RCE Anti-Infective Research Unit est. at Murdoch Children'sPRICE SENSITIVE15/12/22 download Created with Sketch. 319.96KB
RCE Approval to Start Phase I/II Diabetic Foot Ulcer StudyPRICE SENSITIVE09/12/22 download Created with Sketch. 329.13KB
RCE Trading HaltPRICE SENSITIVE07/12/22 download Created with Sketch. 643.19KB
RCE Pause in TradingPRICE SENSITIVE07/12/22 download Created with Sketch. 113.49KB
RCE Change of Director's Interest Notice - A McKeough15/11/22 download Created with Sketch. 300.85KB
RCE Notification regarding unquoted securities - RCE15/11/22 download Created with Sketch. 25.98KB
RCE Constitution14/11/22 download Created with Sketch. 962.98KB
RCE Results of Meeting14/11/22 download Created with Sketch. 248.9KB
RCE AGM Presentation14/11/22 download Created with Sketch. 2.14MB
RCE Investor Presentation - Spark Plus Healthcare Day03/11/22 download Created with Sketch. 2.91MB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/10/22 download Created with Sketch. 581.3KB
RCE Anti-Infective Portfolio Update and Webinar detailsPRICE SENSITIVE19/10/22 download Created with Sketch. 3.36MB
RCE Pause in TradingPRICE SENSITIVE19/10/22 download Created with Sketch. 115.99KB
RCE R327 COVID Study UpdatePRICE SENSITIVE18/10/22 download Created with Sketch. 398.4KB
RCE Pause in tradingPRICE SENSITIVE18/10/22 download Created with Sketch. 115.68KB
RCE Notice of Annual General Meeting/Proxy Form14/10/22 download Created with Sketch. 6.7MB
RCE Expansion and Acceleration of Clinical ProgramsPRICE SENSITIVE27/09/22 download Created with Sketch. 308.99KB
RCE 2022 Annual General Meeting21/09/22 download Created with Sketch. 227.42KB
RCE Cleansing Statement15/09/22 download Created with Sketch. 193.23KB
RCE Application for quotation of securities - RCE15/09/22 download Created with Sketch. 24.79KB
RCE Recce Delivers Opening R&D Address at World AMR Congress07/09/22 download Created with Sketch. 4.56MB
RCE RCE Appoints Dr John Prendergast as Executive Chairman05/09/22 download Created with Sketch. 235.75KB
RCE Initial Director's Interest Notice - A McKeough01/09/22 download Created with Sketch. 203.01KB
RCE Recce Appoints Alistair McKeough to Board of Directors01/09/22 download Created with Sketch. 234.97KB
RCE Appendix 4G31/08/22 download Created with Sketch. 292.15KB
RCE Annual Report to shareholders31/08/22 download Created with Sketch. 4.22MB
RCE Appendix 4EPRICE SENSITIVE31/08/22 download Created with Sketch. 244.24KB
RCE Cleansing Statement22/08/22 download Created with Sketch. 201.62KB
RCE Application for quotation of securities - RCE22/08/22 download Created with Sketch. 24.79KB
RCE Phase I Clinical Trial of R327 I.V. - 6000mg CompletePRICE SENSITIVE22/08/22 download Created with Sketch. 313.84KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE01/08/22 download Created with Sketch. 944.67KB
RCE Corporate Presentation - Aussie Equities Day 2022PRICE SENSITIVE28/07/22 download Created with Sketch. 2.22MB
RCE Dr Philip Sutton - V.P. of Translational Sciences11/07/22 download Created with Sketch. 300.48KB
RCE Phase I Positive Safety Data - 4000mg CompletePRICE SENSITIVE21/06/22 download Created with Sketch. 241.36KB
RCE Cleansing Statement17/06/22 download Created with Sketch. 201.11KB
RCE Application for quotation of securities - RCE16/06/22 download Created with Sketch. 24.94KB
RCE Conversion of Performance Shares16/06/22 download Created with Sketch. 186KB
RCE Cleansing Statement01/06/22 download Created with Sketch. 220.72KB
RCE Application for quotation of securities - RCE01/06/22 download Created with Sketch. 24.8KB
RCE Phase I Clinical Trial R327 Advances to 4000mgPRICE SENSITIVE20/05/22 download Created with Sketch. 241.06KB
RCE MDC: Biotech Investors Luncheon Presentations16/05/22 download Created with Sketch. 2.88MB
RCE Corporate Presentation - Biotech Investor LunchPRICE SENSITIVE16/05/22 download Created with Sketch. 2.48MB
RCE GTG: Biotech Investors Presentation16/05/22 download Created with Sketch. 2.52MB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE02/05/22 download Created with Sketch. 436.79KB
RCE Cleansing Statement12/04/22 download Created with Sketch. 164.34KB
RCE Application for quotation of securities - RCE12/04/22 download Created with Sketch. 24.79KB
RCE Phase I Clinical Trial R327 Advances to High Dose CohortPRICE SENSITIVE12/04/22 download Created with Sketch. 408.22KB
RCE Anti-Viral Patent Granted in Hong KongPRICE SENSITIVE11/04/22 download Created with Sketch. 225.31KB
RCE Cleansing Statement01/04/22 download Created with Sketch. 162.62KB
RCE Application for quotation of securities - RCE01/04/22 download Created with Sketch. 24.79KB
RCE Positive safety data from 4th Cohort -Phase I Clinical TrialPRICE SENSITIVE30/03/22 download Created with Sketch. 247.62KB
RCE $3.08m R&D Rebate ReceivedPRICE SENSITIVE28/03/22 download Created with Sketch. 238.52KB
RCE Safety Committee Clears PhI R327 Dose IncreasePRICE SENSITIVE07/03/22 download Created with Sketch. 265.52KB
RCE S&P DJI Announces March 2022 Quarterly RebalancePRICE SENSITIVE04/03/22 download Created with Sketch. 175.5KB
RCE Appendix 4D and Interim Financial ReportPRICE SENSITIVE28/02/22 download Created with Sketch. 265.76KB
RCE Positive Safety Continues in 3rd Cohort PhI Clinical TrialPRICE SENSITIVE21/02/22 download Created with Sketch. 266.79KB
RCE Cleansing Statement11/02/22 download Created with Sketch. 182.42KB
RCE Notification regarding unquoted securities - RCE11/02/22 download Created with Sketch. 28.94KB
RCE Application for quotation of securities - RCE11/02/22 download Created with Sketch. 24.78KB
RCE Positive Safety Data from Third Cohort of PI Clinical TrialPRICE SENSITIVE08/02/22 download Created with Sketch. 247.91KB
RCE Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/22 download Created with Sketch. 441.2KB
RCE Positive Safety Data from Second Cohort of PI Clinical TrialPRICE SENSITIVE18/01/22 download Created with Sketch. 267.69KB
RCE Positive Safety Data from Phase 1 Clinical TrialPRICE SENSITIVE07/01/22 download Created with Sketch. 316.58KB
RCE Patients to be Dosed in Ph 1 IV Clinical Trial of R327PRICE SENSITIVE15/12/21 download Created with Sketch. 246.15KB
RCE Update on Phase I/II Clinical Trial for Burn Wound InfectionPRICE SENSITIVE07/12/21 download Created with Sketch. 273.37KB
RCE Results of Meeting22/11/21 download Created with Sketch. 177.51KB
RCE AGM Presentation22/11/21 download Created with Sketch. 2.06MB
RCE Opening R&D Address at World AMR CongressPRICE SENSITIVE08/11/21 download Created with Sketch. 6.74MB
RCE Appendix 4C and Activity ReportPRICE SENSITIVE29/10/21 download Created with Sketch. 413.29KB
RCE Ethics Approval to Start Phase 1 Intravenous Clinical TrialPRICE SENSITIVE25/10/21 download Created with Sketch. 247.07KB
RCE Letter to Shareholders - Annual General Meeting22/10/21 download Created with Sketch. 227.26KB
RCE Notice of General Meeting/Proxy Form22/10/21 download Created with Sketch. 853.15KB
RCE Reinstatement to Official QuotationPRICE SENSITIVE12/10/21 download Created with Sketch. 85.72KB
RCE Court Orders GrantedPRICE SENSITIVE12/10/21 download Created with Sketch. 404.72KB
RCE Suspension from Official QuotationPRICE SENSITIVE12/10/21 download Created with Sketch. 240.35KB
RCE Application for quotation of securities - RCE08/10/21 download Created with Sketch. 24.77KB
RCE Court application and delayed cleansing notice08/10/21 download Created with Sketch. 237.22KB
RCE Trading haltPRICE SENSITIVE08/10/21 download Created with Sketch. 696.71KB
RCE Pause in TradingPRICE SENSITIVE08/10/21 download Created with Sketch. 116.55KB
RCE R327 Phase I Clinical Trial Registered on ANZCTRPRICE SENSITIVE30/09/21 download Created with Sketch. 288.3KB
RCE Appendix 4G31/08/21 download Created with Sketch. 269KB
RCE WA Government Sponsorship for BIO Korea 2023
08/05/23 download Created with Sketch. 310.63KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23PRICE SENSITIVE download Created with Sketch. 710.13KB
RCE Ethics Approval to Start Phase I/II (I.V.) Clinical Trial
17/04/23PRICE SENSITIVE download Created with Sketch. 258.68KB
RCE RECCE Trademark Registered - Israel
12/04/23 download Created with Sketch. 263.79KB
RCE New Family 4 Patent to be Granted for RECCE Anti-Infectives
11/04/23PRICE SENSITIVE download Created with Sketch. 272.7KB
RCE Recce Receives Further A$973,144 R&D Advance
04/04/23PRICE SENSITIVE download Created with Sketch. 220.97KB
RCE Corporate Presentation - WI Emergence 2023
23/03/23PRICE SENSITIVE download Created with Sketch. 2.82MB
RCE Appendix 4D and Interim Financial Report
27/02/23PRICE SENSITIVE download Created with Sketch. 312KB
RCE Investor Presentation - Spark Plus Biotech Day
24/02/23 download Created with Sketch. 4.01MB
RCE Recce Selects CMAX for Phase I/II UTI Clinical Trial
20/02/23PRICE SENSITIVE download Created with Sketch. 393.65KB
RCE Cleansing Statement
14/02/23 download Created with Sketch. 158.39KB
RCE Application for quotation of securities - RCE
14/02/23 download Created with Sketch. 24.79KB
RCE RECCE Trademark Registered - Hong Kong
02/02/23 download Created with Sketch. 234.19KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
30/01/23PRICE SENSITIVE download Created with Sketch. 613.04KB
RCE A$6.21m Received from R&D Rebate Payments
25/01/23PRICE SENSITIVE download Created with Sketch. 317.75KB
RCE Cleansing Statement
11/01/23 download Created with Sketch. 159.46KB
RCE Application for quotation of securities - RCE
11/01/23 download Created with Sketch. 24.79KB
RCE JP Morgan Healthcare Conference
10/01/23PRICE SENSITIVE download Created with Sketch. 3.42MB
RCE Australian Patent to be Granted for RECCE Anti-Infectives
10/01/23PRICE SENSITIVE download Created with Sketch. 250.74KB
RCE Anti-Infective Research Unit est. at Murdoch Children's
15/12/22PRICE SENSITIVE download Created with Sketch. 319.96KB
RCE Approval to Start Phase I/II Diabetic Foot Ulcer Study
09/12/22PRICE SENSITIVE download Created with Sketch. 329.13KB
RCE Trading Halt
07/12/22PRICE SENSITIVE download Created with Sketch. 643.19KB
RCE Pause in Trading
07/12/22PRICE SENSITIVE download Created with Sketch. 113.49KB
RCE Change of Director's Interest Notice - A McKeough
15/11/22 download Created with Sketch. 300.85KB
RCE Notification regarding unquoted securities - RCE
15/11/22 download Created with Sketch. 25.98KB
RCE Constitution
14/11/22 download Created with Sketch. 962.98KB
RCE Results of Meeting
14/11/22 download Created with Sketch. 248.9KB
RCE AGM Presentation
14/11/22 download Created with Sketch. 2.14MB
RCE Investor Presentation - Spark Plus Healthcare Day
03/11/22 download Created with Sketch. 2.91MB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
28/10/22PRICE SENSITIVE download Created with Sketch. 581.3KB
RCE Anti-Infective Portfolio Update and Webinar details
19/10/22PRICE SENSITIVE download Created with Sketch. 3.36MB
RCE Pause in Trading
19/10/22PRICE SENSITIVE download Created with Sketch. 115.99KB
RCE R327 COVID Study Update
18/10/22PRICE SENSITIVE download Created with Sketch. 398.4KB
RCE Pause in trading
18/10/22PRICE SENSITIVE download Created with Sketch. 115.68KB
RCE Notice of Annual General Meeting/Proxy Form
14/10/22 download Created with Sketch. 6.7MB
RCE Expansion and Acceleration of Clinical Programs
27/09/22PRICE SENSITIVE download Created with Sketch. 308.99KB
RCE 2022 Annual General Meeting
21/09/22 download Created with Sketch. 227.42KB
RCE Cleansing Statement
15/09/22 download Created with Sketch. 193.23KB
RCE Application for quotation of securities - RCE
15/09/22 download Created with Sketch. 24.79KB
RCE Recce Delivers Opening R&D Address at World AMR Congress
07/09/22 download Created with Sketch. 4.56MB
RCE RCE Appoints Dr John Prendergast as Executive Chairman
05/09/22 download Created with Sketch. 235.75KB
RCE Initial Director's Interest Notice - A McKeough
01/09/22 download Created with Sketch. 203.01KB
RCE Recce Appoints Alistair McKeough to Board of Directors
01/09/22 download Created with Sketch. 234.97KB
RCE Appendix 4G
31/08/22 download Created with Sketch. 292.15KB
RCE Annual Report to shareholders
31/08/22 download Created with Sketch. 4.22MB
RCE Appendix 4E
31/08/22PRICE SENSITIVE download Created with Sketch. 244.24KB
RCE Cleansing Statement
22/08/22 download Created with Sketch. 201.62KB
RCE Application for quotation of securities - RCE
22/08/22 download Created with Sketch. 24.79KB
RCE Phase I Clinical Trial of R327 I.V. - 6000mg Complete
22/08/22PRICE SENSITIVE download Created with Sketch. 313.84KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
01/08/22PRICE SENSITIVE download Created with Sketch. 944.67KB
RCE Corporate Presentation - Aussie Equities Day 2022
28/07/22PRICE SENSITIVE download Created with Sketch. 2.22MB
RCE Dr Philip Sutton - V.P. of Translational Sciences
11/07/22 download Created with Sketch. 300.48KB
RCE Phase I Positive Safety Data - 4000mg Complete
21/06/22PRICE SENSITIVE download Created with Sketch. 241.36KB
RCE Cleansing Statement
17/06/22 download Created with Sketch. 201.11KB
RCE Application for quotation of securities - RCE
16/06/22 download Created with Sketch. 24.94KB
RCE Conversion of Performance Shares
16/06/22 download Created with Sketch. 186KB
RCE Cleansing Statement
01/06/22 download Created with Sketch. 220.72KB
RCE Application for quotation of securities - RCE
01/06/22 download Created with Sketch. 24.8KB
RCE Phase I Clinical Trial R327 Advances to 4000mg
20/05/22PRICE SENSITIVE download Created with Sketch. 241.06KB
RCE MDC: Biotech Investors Luncheon Presentations
16/05/22 download Created with Sketch. 2.88MB
RCE Corporate Presentation - Biotech Investor Lunch
16/05/22PRICE SENSITIVE download Created with Sketch. 2.48MB
RCE GTG: Biotech Investors Presentation
16/05/22 download Created with Sketch. 2.52MB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
02/05/22PRICE SENSITIVE download Created with Sketch. 436.79KB
RCE Cleansing Statement
12/04/22 download Created with Sketch. 164.34KB
RCE Application for quotation of securities - RCE
12/04/22 download Created with Sketch. 24.79KB
RCE Phase I Clinical Trial R327 Advances to High Dose Cohort
12/04/22PRICE SENSITIVE download Created with Sketch. 408.22KB
RCE Anti-Viral Patent Granted in Hong Kong
11/04/22PRICE SENSITIVE download Created with Sketch. 225.31KB
RCE Cleansing Statement
01/04/22 download Created with Sketch. 162.62KB
RCE Application for quotation of securities - RCE
01/04/22 download Created with Sketch. 24.79KB
RCE Positive safety data from 4th Cohort -Phase I Clinical Trial
30/03/22PRICE SENSITIVE download Created with Sketch. 247.62KB
RCE $3.08m R&D Rebate Received
28/03/22PRICE SENSITIVE download Created with Sketch. 238.52KB
RCE Safety Committee Clears PhI R327 Dose Increase
07/03/22PRICE SENSITIVE download Created with Sketch. 265.52KB
RCE S&P DJI Announces March 2022 Quarterly Rebalance
04/03/22PRICE SENSITIVE download Created with Sketch. 175.5KB
RCE Appendix 4D and Interim Financial Report
28/02/22PRICE SENSITIVE download Created with Sketch. 265.76KB
RCE Positive Safety Continues in 3rd Cohort PhI Clinical Trial
21/02/22PRICE SENSITIVE download Created with Sketch. 266.79KB
RCE Cleansing Statement
11/02/22 download Created with Sketch. 182.42KB
RCE Notification regarding unquoted securities - RCE
11/02/22 download Created with Sketch. 28.94KB
RCE Application for quotation of securities - RCE
11/02/22 download Created with Sketch. 24.78KB
RCE Positive Safety Data from Third Cohort of PI Clinical Trial
08/02/22PRICE SENSITIVE download Created with Sketch. 247.91KB
RCE Quarterly Activities/Appendix 4C Cash Flow Report
31/01/22PRICE SENSITIVE download Created with Sketch. 441.2KB
RCE Positive Safety Data from Second Cohort of PI Clinical Trial
18/01/22PRICE SENSITIVE download Created with Sketch. 267.69KB
RCE Positive Safety Data from Phase 1 Clinical Trial
07/01/22PRICE SENSITIVE download Created with Sketch. 316.58KB
RCE Patients to be Dosed in Ph 1 IV Clinical Trial of R327
15/12/21PRICE SENSITIVE download Created with Sketch. 246.15KB
RCE Update on Phase I/II Clinical Trial for Burn Wound Infection
07/12/21PRICE SENSITIVE download Created with Sketch. 273.37KB
RCE Results of Meeting
22/11/21 download Created with Sketch. 177.51KB
RCE AGM Presentation
22/11/21 download Created with Sketch. 2.06MB
RCE Opening R&D Address at World AMR Congress
08/11/21PRICE SENSITIVE download Created with Sketch. 6.74MB
RCE Appendix 4C and Activity Report
29/10/21PRICE SENSITIVE download Created with Sketch. 413.29KB
RCE Ethics Approval to Start Phase 1 Intravenous Clinical Trial
25/10/21PRICE SENSITIVE download Created with Sketch. 247.07KB
RCE Letter to Shareholders - Annual General Meeting
22/10/21 download Created with Sketch. 227.26KB
RCE Notice of General Meeting/Proxy Form
22/10/21 download Created with Sketch. 853.15KB
RCE Reinstatement to Official Quotation
12/10/21PRICE SENSITIVE download Created with Sketch. 85.72KB
RCE Court Orders Granted
12/10/21PRICE SENSITIVE download Created with Sketch. 404.72KB
RCE Suspension from Official Quotation
12/10/21PRICE SENSITIVE download Created with Sketch. 240.35KB
RCE Application for quotation of securities - RCE
08/10/21 download Created with Sketch. 24.77KB
RCE Court application and delayed cleansing notice
08/10/21 download Created with Sketch. 237.22KB
RCE Trading halt
08/10/21PRICE SENSITIVE download Created with Sketch. 696.71KB
RCE Pause in Trading
08/10/21PRICE SENSITIVE download Created with Sketch. 116.55KB
RCE R327 Phase I Clinical Trial Registered on ANZCTR
30/09/21PRICE SENSITIVE download Created with Sketch. 288.3KB
RCE Appendix 4G
31/08/21 download Created with Sketch. 269KB
(20min delay)
Last
46.0¢
Change
0.000(0.00%)
Mkt cap ! $102.0M
Open High Low Value Volume
46.0¢ 46.5¢ 46.0¢ $19.60K 42.56K

Buyers (Bids)

No. Vol. Price($)
3 41004 46.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.5¢ 38272 2
View Market Depth
Last trade - 15.56pm 26/07/2024 (20 minute delay) ?
Last
46.0¢
  Change
0.000 ( 1.08 %)
Open High Low Volume
46.0¢ 47.0¢ 46.0¢ 5566
Last updated 12.56pm 26/07/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.